Literature DB >> 16113406

Revisiting cystic fibrosis transmembrane conductance regulator structure and function.

John W Hanrahan1, My-Anh Wioland.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a channel/enzyme which mediates passive diffusion of chloride and bicarbonate through epithelial cell membranes. It is expressed in many cell types throughout the body, but in the airways it is found mainly in secretory serous cells of the submucosal glands. CFTR belongs to a large super-family of ATP binding cassette transporters that have two nucleotide binding domains with characteristic sequences or "motifs". Although most other ATP binding cassette transporters consume ATP to actively transport various substrates, in CFTR the interactions of ATP with nucleotide binding domains control opening and closing of the channel pore (i.e., channel gating). Recent high resolution structures of bacterial nucleotide binding domains combined with new biochemical and electrophysiological studies of CFTR itself have led to major advances in our understanding of CFTR gating. For example, it is now clear that the ATPase activity of CFTR is not strictly required for its channel activity. CFTR has at least two distinct gating modes; one dependent on hydrolysis and the other requiring only stable ATP binding. In this article we discuss a working hypothesis for CFTR that incorporates these recent findings and discuss some interesting implications of the paradigm shift for other aspects of CFTR function and dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16113406     DOI: 10.1513/pats.2306009

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  8 in total

1.  A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating.

Authors:  Qian Dong; Christoph O Randak; Michael J Welsh
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

2.  Hematopoietic stem/progenitor cells express functional mitochondrial energy-dependent cystic fibrosis transmembrane conductance regulator.

Authors:  Donatella Piro; Claudia Piccoli; Lorenzo Guerra; Francesca Sassone; Annamaria D'Aprile; Maria Favia; Stefano Castellani; Sante Di Gioia; Silvia Lepore; Maria Luisa Garavaglia; Teresa Trotta; Angela Bruna Maffione; Valeria Casavola; Giuliano Meyer; Nazzareno Capitanio; Massimo Conese
Journal:  Stem Cells Dev       Date:  2011-06-20       Impact factor: 3.272

3.  Enhanced Ca2+ entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fibrosis airways.

Authors:  Haouaria Balghi; Renaud Robert; Benjamin Rappaz; Xuexin Zhang; Adeline Wohlhuter-Haddad; Alexandra Evagelidis; Yishan Luo; Julie Goepp; Pasquale Ferraro; Philippe Roméo; Mohamed Trebak; Paul W Wiseman; David Y Thomas; John W Hanrahan
Journal:  FASEB J       Date:  2011-08-26       Impact factor: 5.191

4.  ATP hydrolysis-dependent asymmetry of the conformation of CFTR channel pore.

Authors:  Oleg V Krasilnikov; Ravshan Z Sabirov; Yasunobu Okada
Journal:  J Physiol Sci       Date:  2011-04-03       Impact factor: 2.781

5.  Functional analysis of nonsynonymous single nucleotide polymorphisms in human SLC26A9.

Authors:  An-Ping Chen; Min-Hwang Chang; Michael F Romero
Journal:  Hum Mutat       Date:  2012-06-07       Impact factor: 4.878

Review 6.  Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling.

Authors:  David Nichols; James Chmiel; Melvin Berger
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 7.  Human Genetic Variation Influences Enteric Fever Progression.

Authors:  Pei Yee Ma; Jing En Tan; Edd Wyn Hee; Dylan Wang Xi Yong; Yi Shuan Heng; Wei Xiang Low; Xun Hui Wu; Christy Cletus; Dinesh Kumar Chellappan; Kyan Aung; Chean Yeah Yong; Yun Khoon Liew
Journal:  Cells       Date:  2021-02-06       Impact factor: 6.600

8.  Stimulation of Airway and Intestinal Mucosal Secretion by Natural Coumarin CFTR Activators.

Authors:  Hong Yang; Li-Na Xu; Yu-Jie Sui; Xin Liu; Cheng-Yan He; Rou-Yu Fang; Jia Liu; Feng Hao; Tong-Hui Ma
Journal:  Front Pharmacol       Date:  2011-09-27       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.